摘要
目的合成阿立哌唑并考察优化中间体合成工艺。方法采用7-羟基-3,4-二氢-2(1H)-喹诺酮为起始原料,在碳酸钾存在下,与1,4-二溴丁烷发生醚化生成中间体7-(4-溴丁氧基)-3,4-二氢-2(1H)一喹诺酮(2),在KI和TBAB催化下,继续与N-(2,3-二氯苯基)哌嗪盐酸盐反应,制得目标产物阿立哌唑(1)。在此基础上,对中间体2的合成工艺进行考察,确立了最佳反应条件。结果中间体2和目标产物的结构均已由1H-NMR和MS确证,总收率为67.6%,熔点:139~140℃,与文献报道(139.0~140.0℃)相符。结论和文献报道方法相比,本工艺采用丙酮作为溶剂,代替了文献中采用的DMF溶剂,使合成成本大为降低;采用重结晶的方法进行中间体和目标化合物的纯化,取代了文献中采用的柱层析方法,使操作大为简化,合成工艺更适合于放大合成及工业化。此外,中间体2的合成工艺得到优化后,收率比文献提高了近10%;总收率比文献提高5%.
Objective To prepare aripiprazole( 1 ) and optimize the synthetic process for the intermediate 7- (4-bromobutoxy) -3,4-dihydro-2 (1H) -quinolone (2). Methods 7-Hydroxy-3,4-dihydro-2 (1H) -quinolone reacted with potassium carbonate and 1,4-dibromobutane via etherification to give 2. And then 2 reacted with potassium carbonate and 1- (2,3-dichlorophenyl) piperazine hydrochloride under the catalysis of potas- sium iodide and TBAB to give the target product 1. The synthetic process was researched and the reaction conditions were optimized. Results The structures of intermediate 2 and target 1 had been characterized by IR and 1H-NMR. The overall yield was 67.6%. The mp( 139- 140 ℃ ) of product 1 is consistent with the that (139.0-140.0℃ )reported in the literature. Conclusions Compare with the previous methods in the lit- eratures,this synthesis process was improved by changing the reaction solvent from DMF to acetone to in- crease the purity of 2. Compound 1 could be obtained by recrystallization once instead of separation on col- umns. The changes can reduce the costs and simplify the experimental operations. Besides, through impro- ving the procedureis of intermediate 2, the overall yield is superior 5 % and the yield of intermediate 2 is su- perior 10% to the literatures's,respectively.
出处
《沈阳药科大学学报》
CAS
CSCD
北大核心
2013年第4期253-255,共3页
Journal of Shenyang Pharmaceutical University
关键词
阿立哌唑
抗精神病药物
合成
工艺优化
aripiprazole
antipsychotics
synthesis
process improvement